Measles, mumps and rubella vaccine - KaketsukenAlternative Names: KM-248
Latest Information Update: 30 Dec 2015
At a glance
- Originator Kaketsuken
- Class Measles vaccines; Rubella vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preregistration Measles; Mumps; Rubella
Most Recent Events
- 30 Dec 2015 Preregistration for Measles, Mumps and Rubella in Japan (IM, SC) prior to December 2015 (Kaketsuken pipeline, December 2015) (Kaketsuken pipeline, December 2015)